You are here

Valeant's mistakes raised profit, destroyed value: Ackman

Pharma company raised drug prices sky-high after strategic acquisitions

BT_20160429_DNVALEANT29_2252582.jpg
Mr Pearson told the Congressional committee that "Valeant was too aggressive. And I, as a leader, was too aggressive."

Washington

AFTER US$77 billion in lost market value, congressional hearings and corporate stumbles, Valeant Pharmaceuticals International Inc's CEO and its biggest hedge fund booster stood before a Senate committee, raised their right hands in truth, and said the drug company had gotten...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes